US Patent Issued to FATE THERAPEUTICS on March 11 for "Cellular reprogramming using temporal and transient plasmid vector expression system" (California Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,226, issued on March 11, was assigned to FATE THERAPEUTICS INC. (San Diego).

"Cellular reprogramming using temporal and transient plasmid vector expression system" was invented by Bahram Valamehr (San Diego) and Megan Robinson (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods and compositions for inducing the reprogramming of a non-pluripotent to an iPSC having desirable properties using a vector system providing transient and temporal expression of transgenes that are short-lived. Also provided are reprogramming cells and iPSC populations or clonal cell lines using the provided reprogramming methods and compositions. F...